Ultragenyx Pharmaceutical
RARE
RARE
250 hedge funds and large institutions have $9.36B invested in Ultragenyx Pharmaceutical in 2020 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 97 increasing their positions, 71 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
22% more funds holding
Funds holding: 205 → 250 (+45)
2.09% less ownership
Funds ownership: 104.35% → 102.27% (-2.1%)
Holders
250
Holding in Top 10
1
Calls
$59.6M
Puts
$16.3M
Top Buyers
| 1 | +$155M | |
| 2 | +$66.2M | |
| 3 | +$66.1M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$61.5M |
| 5 |
Goldman Sachs
New York
|
+$60.3M |
Top Sellers
| 1 | -$78.7M | |
| 2 | -$27.1M | |
| 3 | -$26.9M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$24M |
| 5 |
State Street
Boston,
Massachusetts
|
-$19.5M |